Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Spyre Therapeutics, Inc.
Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of SPY072, the First Anti-TL1A Antibody Studied in Rheumatic Diseases
Today 8:00 EDT
From
Spyre Therapeutics, Inc.
Via
GlobeNewswire
Tickers
SYRE
Spyre Therapeutics to Participate in Stifel 2025 Virtual Immunology and Inflammation Forum
September 08, 2025
From
Spyre Therapeutics, Inc.
Via
GlobeNewswire
Spyre Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 05, 2025
From
Spyre Therapeutics, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.